Mary Dooley
Finanzdirektor/CFO bei SYNLOGIC, INC.
Vermögen: 28 330 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Mary Dooley
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 30 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mary Dooley
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal General Counsel | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director of Finance/CFO | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chairman | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chairman | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Boston University | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member | |
| MERRIMACK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| OCATA THERAPEUTICS INC | Pharmaceuticals: Major | Chairman | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| RELYPSA INC | Pharmaceuticals: Major | Director/Board Member | |
| CORNERSTONE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Onset Dermatologics LLC
 Onset Dermatologics LLC Pharmaceuticals: MajorHealth Technology Onset Dermatologics LLC develops and markets prescription product for skin disorders. The company was founded in 2005 and is headquartered in Cumberland, RI. | Pharmaceuticals: Major | Chief Executive Officer | |
| TREVI THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Corporate Officer/Principal Masters Business Admin | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director/Board Member | |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Chairman | |
Indalo Therapeutics, Inc.
 Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chairman | |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chairman | |
Donnelly, Conroy & Gelhaar, LLP
 Donnelly, Conroy & Gelhaar, LLP Miscellaneous Commercial ServicesCommercial Services Donnelly, Conroy & Gelhaar, LLP is a litigation boutique based in Boston, MA. The private company's team of lawyers brings practical strategy, common sense business thinking, and trusted judgment to defending the interests of individuals and companies facing high-stakes challenges to liberty, reputation, or financial position. The company provides legal services in white collar defense & government investigations, SEC enforcement defense, business litigation, complex business litigation, merger & acquisition disputes, intellectual property litigation, employment litigation, corporate governance & shareholder disputes, arbitration & mediation, and appellate litigation. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Medxtend Corp. | Chief Executive Officer | ||
Avenge Bio, Inc.
 Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Avenge Bio, Inc. is an oncology-focused biotechnology company based in the United States. The American company develops cell-based immunotherapeutic products for the treatment of solid tumors using its proprietary Lococyte™ platform. The platform delivers engineered cells to the local tumor environment, generating high concentrations of immune effector molecules in proximity to the tumor, which initiates a robust, local, and durable systemic immune response while avoiding toxicities associated with systemic immunotherapies. Avenge's most advanced product candidate, AVB-001, produces native IL-2 immunotherapy and is initially being studied in metastatic peritoneal cancers such as ovarian cancer. The company has additional pipeline candidates for the treatment of a wide range of cancers, including pancreatic, lung, and breast cancers. Avenge was founded in 2019 by Paul Kevin Wotton and Michael Thomas Heffernan, with Heffernan serving as CEO since incorporation. | Pharmaceuticals: Major | Founder | |
| 2SEVENTY BIO, INC. | Pharmaceuticals: Major | Chairman | |
K36 Therapeutics, Inc.
 K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | Pharmaceuticals: Major | Director/Board Member | |
| BIOHAVEN LTD. | Pharmaceuticals: Major | Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor |
Statistik
International
| Vereinigte Staaten | 47 |
| Dänemark | 3 |
Sektoral
| Health Technology | 37 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Finance | 3 |
Operativ
| Director/Board Member | 173 |
| Corporate Officer/Principal | 69 |
| Independent Dir/Board Member | 60 |
| Chairman | 29 |
| Director of Finance/CFO | 26 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Michael Powell | 48 |
| Ed Mathers Mathers | 47 |
| Peter Barrett | 38 |
| Chau Khuong | 38 |
| Michael Heffernan | 23 |
| Gregg Beloff | 18 |
| Andrew Gengos | 15 |
| Nick Leschly | 13 |
| Michael Burgess | 12 |
| Aoife Brennan | 10 |
| Christine Guertin | 10 |
| Michael R. Slater | 9 |
| Todd Shegog | 9 |
| Lisa Kelly-Croswell | 9 |
| Patricia Hurter | 8 |
- Börse
- Insiders
- Mary Dooley
- Unternehmensverbindungen
